Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination
Date
2021-04-23Journal
JAMA Network OpenPublisher
American Medical AssociationType
Article
Metadata
Show full item recordAbstract
OBJECTIVE: To estimate the benefits of identifying silent infections among children as a proxy for their vaccination. DESIGN, SETTING, AND PARTICIPANTS: This study used an age-structured disease transmission model, parameterized with census data and estimates from published literature, to simulate the estimated synergistic effect of interventions in reducing attack rates during the course of 1 year among a synthetic population representative of the US demographic composition. The population included 6 age groups of 0 to 4, 5 to 10, 11 to 18, 19 to 49, 50 to 64, and 65 years or older based on US census data. Data were analyzed from December 12, 2020, to February 26, 2021. EXPOSURES: In addition to the isolation of symptomatic cases within 24 hours of symptom onset, vaccination of adults was implemented to reach a 40% to 60% coverage during 1 year with an efficacy of 95% against symptomatic and severe COVID-19. MAIN OUTCOMES AND MEASURES: The combinations of proportion and speed for detecting silent infections among children that would suppress future attack rates to less than 5%. RESULTS: In the base-case scenarios with an effective reproduction number Re = 1.2, a targeted approach that identifies 11% of silent infections among children within 2 days and 14% within 3 days after infection would bring attack rates to less than 5% with 40% vaccination coverage of adults. If silent infections among children remained undetected, achieving the same attack rates would require an unrealistically high vaccination coverage (≥81%) of this age group, in addition to 40% vaccination coverage of adults. The estimated effect of identifying silent infections was robust in sensitivity analyses with respect to vaccine efficacy against infection and reduced susceptibility of children to infection. CONCLUSIONS AND RELEVANCE: In this simulation modeling study of a synthetic US population, in the absence of vaccine availability for children, a targeted approach to rapidly identify silent COVID-19 infections in this age group was estimated to significantly mitigate disease burden. These findings suggest that without measures to interrupt transmission chains from silent infections, vaccination of adults is unlikely to contain the outbreaks in the near term.Keyword
silent COVID-19 infectionsimulation modeling study
Children
COVID-19
Disease Transmission, Infectious
Identifier to cite or link to this item
http://hdl.handle.net/10713/15515ae974a485f413a2113503eed53cd6c53
10.1001/jamanetworkopen.2021.7097
Scopus Count
Related articles
- Simulated identification of silent COVID-19 infections among children and estimated future infection rates with vaccination.
- Authors: Moghadas SM, Fitzpatrick MC, Shoukat A, Zhang K, Galvani AP
- Issue date: 2021 Feb 26
- Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
- Authors: Patel MD, Rosenstrom E, Ivy JS, Mayorga ME, Keskinocak P, Boyce RM, Hassmiller Lich K, Smith RL 3rd, Johnson KT, Delamater PL, Swann JL
- Issue date: 2021 Jun 1
- Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.
- Authors: Giardina J, Bilinski A, Fitzpatrick MC, Kendall EA, Linas BP, Salomon J, Ciaranello AL
- Issue date: 2022 Feb 1
- Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.
- Authors: Paltiel AD, Zheng A, Walensky RP
- Issue date: 2020 Jul 1
- Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York.
- Authors: Dawood FS, Porucznik CA, Veguilla V, Stanford JB, Duque J, Rolfes MA, Dixon A, Thind P, Hacker E, Castro MJE, Jeddy Z, Daugherty M, Altunkaynak K, Hunt DR, Kattel U, Meece J, Stockwell MS
- Issue date: 2022 Jan 1